New vaccine at the door: Moderna begins antidote trials against omicron variant
Moderna is the third drugmaker to announce trials of a vaccine against the omicron variant this week. Photo: Maddie Meyer/Getty Images modern announced this Wednesday that it began the second-phase clinical trials of its vaccine for fight the omicron variant of covid-19. The Massachusetts-based pharmaceutical company indicated that this phase of the study will include …
New vaccine at the door: Moderna begins antidote trials against omicron variant Read More »